TFF Pharmaceuticals, Inc. (TFFP) Financials

NASDAQ Currency in USD Disclaimer

$0.07

south_east -$0.1 (-60.05%)
Day's range
$0.06
Day's range
$0.09

TFFP Income statement / Annual

Last year (2023), TFF Pharmaceuticals, Inc.'s total revenue was $733,871.00, and the percentage change from the previous year is not available. In 2023, TFF Pharmaceuticals, Inc.'s net income was -$21.24 M. See TFF Pharmaceuticals, Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $733,871.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $502,480.00 $388,221.00 $111,453.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $231,391.00 -$388,221.00 -$111,453.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0.32 0 0 0 0 0 0 0
Research and Development Expenses $11.56 M $18.50 M $21.30 M $10.68 M $8.82 M $848,809.00 $0.00 $229,259.00
General & Administrative Expenses $10.57 M $13.80 M $10.57 M $8.01 M $3.17 M $0.00 $178,605.00 $0.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $10.57 M $13.80 M $10.57 M $8.01 M $3.17 M $3.05 M $178,605.00 $141,111.00
Other Expenses $0.00 -$495,805.00 -$88,161.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $22.63 M $31.80 M $31.79 M $18.69 M $11.99 M $3.90 M $178,605.00 $370,370.00
Cost And Expenses $22.63 M $31.80 M $31.79 M $18.69 M $11.99 M $3.90 M $178,605.00 $370,370.00
Interest Income $0.00 $26,728.00 $51,232.00 $126,416.00 $117,329.00 $55,960.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $502,480.00 $388,221.00 $111,453.00 $206,297.00 $171,860.00 $0.00 $52,516.00 $0.00
EBITDA -$20.74 M -$31.41 M -$30.93 M -$18.69 M -$11.99 M -$3.90 M -$178,605.00 -$370,370.00
EBITDA Ratio -28.26 0 0 0 0 0 0 0
Operating Income Ratio -29.83 0 0 0 0 0 0 0
Total Other Income/Expenses Net $651,431.00 $26,728.00 $747,946.00 $126,416.00 $117,329.00 $55,964.00 $0.00 $0.00
Income Before Tax -$21.24 M -$31.77 M -$31.04 M -$18.57 M -$11.87 M -$3.84 M -$178,605.00 -$370,370.00
Income Before Tax Ratio -28.95 0 0 0 0 0 0 0
Income Tax Expense $0.00 -$26.73 -$51,232.00 -$126,416.00 -$117,329.00 $0.00 -$52,521.00 $0.00
Net Income -$21.24 M -$31.77 M -$30.99 M -$18.44 M -$11.75 M -$3.84 M -$178,605.00 -$370,370.00
Net Income Ratio -28.95 0 0 0 0 0 0 0
EPS -11.85 -26.49 -31.21 -22.57 -42.55 -5.21 -0.01 -0.5
EPS Diluted -11.85 -26.49 -31.21 -22.57 -42.55 -5.21 -0.01 -0.5
Weighted Average Shares Out $1.79 M $1.20 M $992,838.00 $817,006.00 $276,199.00 $738,039.00 $17.83 M $738,039.00
Weighted Average Shares Out Diluted $1.79 M $1.20 M $992,838.00 $817,006.00 $276,199.00 $738,039.00 $17.83 M $738,039.00
Link